M&A Deal Summary |
|
|---|---|
| Date | 2020-02-12 |
| Target | Psilocin Pharma |
| Sector | Life Science |
| Buyer(s) | Revive Therapeutics |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2012 |
| Sector | Life Science |
| Revenue | 6M CAD (2023) |
Revive Therapeutics is a life sciences company focused on the research, development, and commercialization of novel cannabinoid-based products. Revive’s novel cannabinoid delivery technology is being advanced to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory and liver diseases. Revive Therapeutics was founded in 2012 and is based in Toronto, Ontario.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Ontario M&A | 2 of 2 |
| Country: Canada M&A | 2 of 2 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-11-12 |
Greeninsightz
Toronto, Ontario, Canada Greeninsightz Ltd. is an artificial intelligence data software company focused on the cannabis sector. reenInsightz uses patented technology to look at data sets from leading social media, blogs, and other forums to help target patients and recreational users. The technology helps identify strain protocols preferred and allows more effective marketing for the cannabis or clinic provider. |
Buy | - |
